Cheri Prather

https://conta.cc/46l3OTn Pfizer’s hemophilia A gene therapy met primary endpoint and is likely on the path to approval. However, this small tailwind cannot overcome the headwinds from the challenging commercial outlook of Pfizer’s gene therapy franchise. Our editor Jiamin Zhuo has more. Another major volatility in the obesity market was caused by a faster-than-expected phase 3 trial timeline from Viking Therapeutics. On the news of Viking’s faster than expected phase 3 pivotal trial plan, Eli Lilly and Novo Nordisk lost $70Bn market cap. Our editor Leon Tang has more. Other global biotech news includes the rejection of Eisai/Biogen’s Alzheimer’s drug lecanemab by the EMA; US presidential candidate Kamala Harris’ special relationship with cancer research through family tie; and the opportunities and challenges facing China biotechs that are out licensing assets from immunology & inflammation space.

Only put off until tomorrow what you are willing to die having left undone. ## Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea Shares of \*\*Regeneron Pharmaceuticals, Inc. \(REGN\)\*\* were down 4.63% after an unfavorable ruling in its lawsuit against \*\*Amgen \(AMGN\)\*\* in the United States District Court for the Northern District of West Virginia. The lawsuit was related to a biosimilar of its lead drug Eylea \(aflibercept 2 mg\). Regeneron's shares have rallied 24.3% so far this year, driven by strong performance in its pharmaceutical business and positive clinical trial results. However, this court ruling has led to a decline in the stock price. As an investor, it is essential to stay informed about developments that can impact your investments. Health Savings Accounts \(HSAs\) offer a unique opportunity to invest in healthcare-related companies such as Regeneron Pharmaceuticals. By effectively managing your HSA portfolio, you can potentially grow your savings while simultaneously supporting the healthcare industry. Don't miss out on the potential benefits of investing in healthcare. Act now and explore the opportunities available with your HSA. Invest in your health, your family's well-being, and secure your financial future. #hsa #investing #healthcare #health #family #wellness 💪💰🏥

Thoughts on this? >> Bristol Myers Squibb returns TIGIT bispecific to Agenus, ends $1.5B pact >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #productmarketing